The oligodendrocyte-specific antibody ‘CC1’ binds Quaking 7

97Citations
Citations of this article
145Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The mouse monoclonal antibody marketed as anti-adenomatous polyposis coli clone CC1, often referred to as CC1, is the antibody most commonly used to specifically label mature oligodendrocytes without labeling myelin. Previous studies have shown that despite being raised against adenomatous polyposis coli, this antibody binds another unknown antigen. We show that the CC1 antibody binds Quaking 7, an RNA-binding protein that is highly up-regulated in myelinating oligodendrocytes in the central nervous system. (Figure presented.) The monoclonal antibody anti-adenomatous polyposis coli (APC) clone CC1, is the antibody most commonly used to specifically label the cell bodies of mature oligodendrocytes. Despite being raised against APC, previous studies showed this antibody binds another unknown antigen. We show that the CC1 antibody binds Quaking (QKI) 7, an RNA-binding protein which is highly up-regulated in myelinating oligodendrocytes.

Author supplied keywords

Cite

CITATION STYLE

APA

Bin, J. M., Harris, S. N., & Kennedy, T. E. (2016). The oligodendrocyte-specific antibody ‘CC1’ binds Quaking 7. Journal of Neurochemistry, 181–186. https://doi.org/10.1111/jnc.13745

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free